Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy.
Mayo Clin Proc
; 77(12): 1340-3, 2002 Dec.
Article
em En
| MEDLINE
| ID: mdl-12479522
ABSTRACT
Abciximab has a key role in the treatment of patients with acute coronary syndromes undergoing percutaneous coronary intervention; however, an increased risk of bleeding complications is well recognized. We report a case of serious pulmonary hemorrhage after use of abciximab therapy. A definitive indication and treatment guideline should be available to minimize serious bleeding complications. Additionally, respiratory symptoms should be monitored closely for early detection of serious pulmonary hemorrhage in patients receiving abciximab therapy during percutaneous coronary intervention.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fragmentos Fab das Imunoglobulinas
/
Complexo Glicoproteico GPIIb-IIIa de Plaquetas
/
Hemorragia
/
Pneumopatias
/
Anticorpos Monoclonais
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Screening_studies
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Mayo Clin Proc
Ano de publicação:
2002
Tipo de documento:
Article